Contact Us
  Search
The Business Research Company Logo
Global Negative Pressure Wound Therapy Market Report 2026
Published :January 2026
Pages :150
Format :PDF
Delivery Time :2-3 Business Days
Why 2-3 days? We update the report with the latest data and news before delivery. Let us know if you need us to expedite.
Report Price :$4,490.00

Negative Pressure Wound Therapy Market Report 2026

Global Outlook – By Product (Conventional NPWT Devices, Single Use NPWT Devices ), By Wound Type (Surgical And Traumatic Wounds, Ulcers, Burns ), By End User (Hospitals, Homecare, Other End-Users) - Market Size, Trends, And Global Forecast 2026-2035

Negative Pressure Wound Therapy Market Overview

• Negative Pressure Wound Therapy market size has reached to $3.36 billion in 2025 • Expected to grow to $4.94 billion in 2030 at a compound annual growth rate (CAGR) of 8.4% • Growth Driver: Rising Prevalence Of Diabetes To Drive Market Growth • Market Trend: Product Innovations Reshaping The Negative Pressure Wound Therapy Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.
Research Expert

Book your 30 minutes free consultation with our research experts

What Is Covered Under Negative Pressure Wound Therapy Market?

Negative-pressure wound therapy (NPWT) is a therapeutic technique that uses a vacuum dressing to promote healing in acute or chronic wounds and enhances healing of second and third-degree burns. The main product types of negative-pressure wound therapy are conventional NPWT devices, single-use NPWT devices. Conventional NPWT (Negative Pressure Wound Therapy) devices are a type of wound therapy device that consists of a filler, such as foam or gauze, which covers the wound and a permeable membrane and tubing that connects the space under the membrane.
Negative Pressure Wound Therapy Market Global Report 2026 Market Report bar graph

What Is The Negative Pressure Wound Therapy Market Size and Share 2026?

The negative pressure wound therapy market size has grown strongly in recent years. It will grow from $3.36 billion in 2025 to $3.58 billion in 2026 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to increasing incidence of chronic wounds, rising number of surgical procedures, growth in diabetic and elderly populations, expansion of hospital wound care programs, availability of advanced wound therapy devices.

What Is The Negative Pressure Wound Therapy Market Growth Forecast?

The negative pressure wound therapy market size is expected to see strong growth in the next few years. It will grow to $4.94 billion in 2030 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to increasing adoption of home healthcare services, rising focus on cost-effective wound management, expansion of outpatient care settings, growing demand for disposable wound care solutions, increasing technological innovation in wound therapy devices. Major trends in the forecast period include increasing adoption of portable npwt systems, rising demand for single-use npwt devices, growing focus on home-based wound care solutions, expansion of advanced dressing materials, enhanced emphasis on faster wound healing outcomes.

Global Negative Pressure Wound Therapy Market Segmentation

1) By Product: Conventional NPWT Devices, Single Use NPWT Devices 2) By Wound Type: Surgical And Traumatic Wounds, Ulcers, Burns 3) By End User: Hospitals, Homecare, Other End-Users Subsegments: 1) By Conventional NPWT Devices: Portable NPWT Systems, Stationary NPWT Systems, Canister-Based NPWT Devices 2) By Single-Use NPWT Devices: Disposable NPWT Systems, Battery-Operated NPWT Devices, Compact NPWT Units

What Is The Driver Of The Negative Pressure Wound Therapy Market?

The growing prevalence of diabetes is expected to propel the growth of the negative pressure wound therapy market. Diabetic foot ulceration (DFU) is the most common application area of negative pressure wound therapy. A diabetic person's wounds are difficult to heal because people with uncontrolled diabetes may develop poor circulation, which results in less oxygenated circulation to the wound and the tissues do not heal as quickly. Thus, negative pressure wound therapy offers better graft take-up than conventional dressing for diabetic patients. For instance, in July 2023, the International Diabetes Federation (IDF), a Belgum-based non-profit organization, reported that 540 million people aged 20-79 were living with diabetes in 2022, with the number projected to rise to 643 million by 2030 and 783 million by 2045. Therefore, the growing prevalence of diabetes drives the negative pressure wound therapy industry.

Key Players In The Global Negative Pressure Wound Therapy Market

Major companies operating in the negative pressure wound therapy market are Devon International Group, ConvaTec Group plc., DeRoyal Industries Inc., Smith & Nephew plc, Acelity L.P. Inc., Mölnlycke Health Care AB, ATMOS MedizinTechnik GmbH & Co. KG, Cardinal Health Inc., Talley Group Limited, Medela AG, Lohmann & Rauscher GmbH & Co. KG, Triage Meditech Pvt. Ltd., Carilex Medical GmbH, Shandong Weigao Xinsheng Medical Devices Co. Lt, Genadyne Biotechnologies Inc., B. Braun Melsungen AG, Cork Medical LLC, BSN medical GmbH, Investor AB, Olle Larsson Holding AG, PAUL HARTMANN Asia-Pacific Ltd., KCI Licensing Inc., Arjo USA Inc., 3M Company, MPM Medical Inc., Prospera Technologies Inc., Innovative Therapies Inc., Laboratoires URGO, 4L Health Co. Ltd, Pensar Medical LLC, Virchow Biotech Pvt. Ltd., Arobella Medical LLC, Spincare Inc., Ursapharm Arzneimittel GmbH

What Are Latest Mergers And Acquisitions In The Negative Pressure Wound Therapy Market?

In November 2025, Pensar Medical Inc., a US-based medical device company focused on innovative wound care solutions, partnered with Centurion Therapeutics, Inc. to develop and commercialize a next-generation negative pressure wound therapy (NPWT) system. With this partnership, Pensar Medical, Inc. and Centurion Therapeutics, Inc. aim to combine Pensar’s innovative wound management technology with Centurion’s expertise in therapeutic development to improve patient outcomes, enhance wound healing efficiency, and expand access to advanced NPWT solutions. Centurion Therapeutics Inc. is a US-based biopharmaceutical company specializing in the development of innovative therapies for complex medical conditions.

Regional Outlook

North America was the largest region in the negative pressure wound therapy market in 2025. Asia-Pacific is the fastest-growing region in the negative pressure wound therapy market share. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Need data on a specific region in this market?

What Defines the Negative Pressure Wound Therapy Market?

The negative-pressure wound therapy (NPWT) market consists of sales of conventional NPWT devices, disposable NPWT devices, and NPWT accessories. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Negative Pressure Wound Therapy Market Report 2026?

The negative pressure wound therapy market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the negative pressure wound therapy industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Negative Pressure Wound Therapy Market Report Forecast Analysis

Report Attribute Details
Market Size Value In 2026$3.58 billion
Revenue Forecast In 2035$4.94 billion
Growth RateCAGR of 6.4% from 2026 to 2035
Base Year For Estimation2025
Actual Estimates/Historical Data2020-2025
Forecast Period2026 - 2030 - 2035
Market RepresentationRevenue in USD Billion and CAGR from 2026 to 2035
Segments CoveredProduct, Wound Type, End User
Regional ScopeAsia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country ScopeThe countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies ProfiledDevon International Group, ConvaTec Group plc., DeRoyal Industries Inc., Smith & Nephew plc, Acelity L.P. Inc., Mölnlycke Health Care AB, ATMOS MedizinTechnik GmbH & Co. KG, Cardinal Health Inc., Talley Group Limited, Medela AG, Lohmann & Rauscher GmbH & Co. KG, Triage Meditech Pvt. Ltd., Carilex Medical GmbH, Shandong Weigao Xinsheng Medical Devices Co. Lt, Genadyne Biotechnologies Inc., B. Braun Melsungen AG, Cork Medical LLC, BSN medical GmbH, Investor AB, Olle Larsson Holding AG, PAUL HARTMANN Asia-Pacific Ltd., KCI Licensing Inc., Arjo USA Inc., 3M Company, MPM Medical Inc., Prospera Technologies Inc., Innovative Therapies Inc., Laboratoires URGO, 4L Health Co. Ltd, Pensar Medical LLC, Virchow Biotech Pvt. Ltd., Arobella Medical LLC, Spincare Inc., Ursapharm Arzneimittel GmbH
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options
Chat with us